Original language | English (US) |
---|---|
Pages (from-to) | 1535-1539 |
Number of pages | 5 |
Journal | Leukemia |
Volume | 33 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1 2019 |
Externally published | Yes |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Mutant p53 enhances leukemia-initiating cell self-renewal to promote leukemia development. / Nabinger, Sarah C.; Chen, Sisi; Gao, Rui et al.
In: Leukemia, Vol. 33, No. 6, 01.06.2019, p. 1535-1539.Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Mutant p53 enhances leukemia-initiating cell self-renewal to promote leukemia development
AU - Nabinger, Sarah C.
AU - Chen, Sisi
AU - Gao, Rui
AU - Yao, Chonghua
AU - Kobayashi, Michihiro
AU - Vemula, Sasidhar
AU - Fahey, Aidan C.
AU - Wang, Christine
AU - Daniels, Cecil
AU - Boswell, H. Scott
AU - Sandusky, George E.
AU - Mayo, Lindsey D.
AU - Kapur, Reuben
AU - Liu, Yan
N1 - Funding Information: Acknowledgements This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Bone Marrow Failure Research Program—Idea Development Award under Award No. W81XWH-18-1-0265 to YL. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. This work was also supported in part by two NIH R56 Awards (R56DK119524-01 and R56AG05250), a DoD Career Development Award W81XWH-13-1-0187, a Scholar Award from the St. Baldrick’s Foundation, an Elsa Pardee Foundation New Investigator Award, a Leukemia Research Foundation New Investigator Award, a Showalter Trust Fund New Investigator Award, an Alex Lemonade Stand Foundation grant, a Children’s Leukemia Research Association grant, and an American Cancer Society Institutional Research Grant to YL. SCN was supported by a NIH F32 Award 1F32CA203049-01.The authors would like to acknowledge the Flow Cytometry Core and In vivo Therapeutic Core Laboratories, which were sponsored, in part, by the NIDDK Cooperative Center of Excellence in Hematology (CCEH) grant U54 DK106846. This work was supported, in part, by a Project Development Team within the ICTSI NIH/NCRR Grant Number UL1TR001108. We would like to thank Dr. Yang Xu at USCD for providing the p53R248Wmice to the study.
PY - 2019/6/1
Y1 - 2019/6/1
UR - http://www.scopus.com/inward/record.url?scp=85060583910&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060583910&partnerID=8YFLogxK
U2 - 10.1038/s41375-019-0377-0
DO - 10.1038/s41375-019-0377-0
M3 - Letter
C2 - 30675010
AN - SCOPUS:85060583910
SN - 0887-6924
VL - 33
SP - 1535
EP - 1539
JO - Leukemia
JF - Leukemia
IS - 6
ER -